Elzanor 12.5/500mg Tablet 14s

Metformin primarily works by suppressing hepatic glucose production. It inhibits gluconeogenesis and glycogenolysis in the liver, reducing the amount of glucose released into the bloodstream. Metformin also enhances insulin sensitivity in peripheral tissues, particularly in skeletal muscles, where it increases glucose uptake and utilization. Additionally, it may indirectly reduce appetite, leading to decreased food intake and calorie absorption. Empagliflozin, on the other hand, is an SGLT2 (sodium-glucose cotransporter-2) inhibitor.